Plain-English translation of NCT05711849 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 2 โ Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
REGENERATE-COBRA is testing whether autologous bone marrow cells โ cells taken from your own bone marrow and processed in a lab โ can reduce chest pain in people whose angina hasn't improved despite taking multiple heart medicines. Half of the participants will receive the real stem cell treatment injected into their coronary arteries, while half will receive a sham (fake) procedure that looks and feels the same. All participants will be blindfolded during their procedures so they don't know which group they're in.
Some people have severe chest pain that doesn't get better even with the strongest available medicines and aren't candidates for surgery or angioplasty. This trial is exploring whether stem cells from the patient's own bone marrow can help restore blood flow and reduce pain in these cases.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you're selected, you'll have a bone marrow aspiration procedure (where cells are collected from your hip bone) and then a single infusion of cells into your heart arteries โ or a sham version of both procedures if you're in the control group. You'll be blindfolded and wear noise-cancelling headphones so you don't know which group you're in. After the procedure, you'll have a phone call at 1 month, a clinic visit at 6 months, and another phone call at 12 months to track how your chest pain has changed.
AI-generated summary from trial data ยท Jul 7, 2026 ยท Not medical advice
United Kingdom